Lilly, Walmart launch discount retail option for weight-loss drug Zepbound
Go back to Lilly, Walmart launch discount retail option for weight-loss drug Zepbound| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1255.40 +11.00 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1244.40 | 52 Week High | $88.16 | |||
| Open | $1232.00 | 52 Week Low | $67.88 | |||
| Day High | $1271.22 | P/E | 290.60 | |||
| Day Low | $1230.00 | EPS | $4.32 | |||
| Volume | 2,505,585 | |||||
| Wal-Mart Stores (NASDAQ: WMT) | Delayed: 103.70 -0.14 (0.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $103.84 | 52 Week High | $75.19 | |||
| Open | $103.68 | 52 Week Low | $56.36 | |||
| Day High | $104.28 | P/E | 21.38 | |||
| Day Low | $102.15 | EPS | $4.85 | |||
| Volume | 44,438,455 | |||||
